All
GE Healthcare Launches Cytiva Plus Cardiomyocytes
GE Healthcare introduces the Cytiva Plus Cardiomyocytes, a high fidelity human heart cell model.
Bristol-Myers Squibb Enters Cancer Research Collaborations
Bristol-Myers Squibb announced collaborations with CytomX on probodies and with Incyte in an immunotherapy clinical trial.
Report:Positive Outlook for Investment in Global Pharma and Biotech Industry
Research from Frost & Sullivan indicates a strong comeback of IPOs suggesting a positive outlook for investment in the pharmaceutical and biotechnology industry.
GSK Selects Genedata Biologics as Antibody Discovery Platform
GSK selects Genedata Biologics as an R&D data management and workflow-support platform.
Array BioPharma and Biogen Idec Collaborate on Kinase Inhibitors
The companies aim to discover and develop kinase inhibitors for treating autoimmune disorders.
Rockland Immunochemicals Expands Laboratories
Rockland Immunochemicals develops new laboratories in Limerick, PA.
BioPlan Associates Releases 11th Annual Global Biomanufacturing Study
The 11th Annual Global Biomanufacturing Study includes a global analysis of 238 biomanufacturers and 178 suppliers in 31 countries.
FDA Targets Illegal Online Pharmacies
FDA targets illegal online pharmacies that sell unapproved prescription drugs to US consumers.
EMD Millipore Expands Provantage Upstream Bioproduction Services
EMD Millipore expands its Provantage upstream bioproduction services into North America.
Selexys Pharmaceuticals Signs CMO Agreement with Cytovance Biologics
Cytovance Biologics and Selexys Pharmaceuticals enter an agreement for development of clinical trial materials.
Kymab Receives $40 Million Investment From Gates Foundation and Wellcome Trust
Kymab receives $40 million investment for clinical development of antibody therapeutics.
Merck KGaA Invests in Biopharmaceuticals Fill-Finish Site
Merck KGaA fill-finish expansion in Italy will be completed in 2017.
SAFC Installs Continuous-Flow Reactor
SAFC offers commercial and pilot-scale continuous-flow capacity.
FDA Approves Entyvio for Ulcerative Colitis and Crohn's Disease
DA approves Entyvio, an injection to treat adult patients with moderate to severe ulcerative colitis and Crohn's disease.
FDA Issues Complete Response Letter for Novartis' RLX030
FDA issues complete response letter for Novartis' RLX030 for acute heart failure.
Meissner Begins Operations At New Headquarters
Meissner moves into its new headquarters in Camarillo, California.
SGS Announces Appointments at New Facility in California
SGS makes two senior appointments at its new GMP/GLP laboratory in Carson, California.
AstraZeneca Rejects Pfizer's Final Offer
AstraZeneca rejects Pfizer's final offer of $118 billion for a proposed merger of the two companies.
Advanced Scientifics and Chemic Laboratories Announce Joint Cooperation Agreement
Advanced Scientifics and Chemic Laboratories enter a three-year joint cooperation agreement to collaborate on product development projects.
Novasep Commissions Plant Extension for Highly Potent APIs
New manufacturing capacity at the Le Mans, France facility is being used to scale up antibody drug conjugates.
AstraZeneca and MRC Laboratory of Molecular Biology Launch Joint Research Fund
AstraZeneca will collaborate with the Medical Research Council Laboratory of Molecular Biology to fund a range of pre-clinical research projects.
EMA Opens Registration for European Network of Paediatric Research Workshop
EMA opens registration for it's sixth annual workshop on pediatric drug research and development.
Hilary Clinton to Deliver Keynote at BIO International Convention
Hillary Clinton will deliver a keynote address at the 2014 BIO International Convention in San Diego.
FDA and EMA Join Forces on Treatment of Gaucher Disease in Children
FDA and EMA release a draft joint proposal on the development of new drugs to treat Gaucher disease in children.
FDA Releases Q&A on ANDAs and Stability Testing
FDA clarifies stability data recommendations for abbreviated new drug applications.
FDA Releases Draft Guidance on Biosimilarity
Draft guidance addresses the use of clinical pharmacology studies to determine biosimilarity of biologics.
Eurofins to Acquire ViraCor-IBT Laboratories
Eurofins Scientific will acquire ViraCor-IBT Laboratories for $255 million.
KBI Biopharma Acquires Merck's Biologics Operations
KBI Biopharma acquires Merck's microbial process development and manufacturing operations in Colorado.
Shire Acquires Lumena Pharmaceuticals
Shire expands rare disease portfolio with acquisition of Lumena Pharmaceuticals.
Cumberland Pharmaceuticals and Gloria Pharmaceuticals Announce R&D Investment
Cumberland Pharmaceuticals and Gloria Pharmaceuticals invest $1 million each in Cumberland Emerging Technologies.
